Cech named science adviser to STORM Therapeutics

Thomas CechSTORM Therapeutics has named Thomas Cech as a science adviser.

Founded in 2015, STORM Therapeutics is a British-based developer of small-molecule inhibitors of RNA-modifying enzymes for the treatment of cancer.

A leading figure in the field of RNA research, Cech shared the 1989 Nobel Prize in chemistry for discovering the catalytic properties of RNA. He also received the Albert Lasker Basic Medical Research Award and the National Medal of Science.

Cech is a distinguished professor of chemistry and biochemistry at the University of Colorado, Boulder, and director of the BioFrontiers Institute, an interdisciplinary bioscience research and education hub with a focus on improving human health.

Read more member news from the March issue of ASBMB Today.